share_log

藥明康德：完成向計劃受託人直接回購H股股份及註銷該等H股股份

WUXI APPTEC: COMPLETION OF DIRECT REPURCHASE OF H SHARES FROM THE SCHEME TRUSTEE AND CANCELLATION OF SUCH H SHARES

香港交易所 ·  Jan 18 05:22
Summary by Moomoo AI
药明康德於2024年1月15日完成了對2023年H股獎勵信託計劃所涉股份的回購及註銷，涉及股份總數為15,467,500股，約佔公司已發行股本總額的0.52%。此次回購及註銷是根據2024年1月5日股東大會的特別決議通過後進行的，並且不會影響公司公眾持股量符合《上市規則》的要求。完成後，公司註冊資本相應減少人民幣15,467,500元，並將進行相關的公司章程修改及備案登記手續。股份註銷後，H股股份數目由402,543,650股減至387,076,150股。董事會成員包括執行董事李革博士等，以及非執行董事和獨立非執行董事。
药明康德於2024年1月15日完成了對2023年H股獎勵信託計劃所涉股份的回購及註銷，涉及股份總數為15,467,500股，約佔公司已發行股本總額的0.52%。此次回購及註銷是根據2024年1月5日股東大會的特別決議通過後進行的，並且不會影響公司公眾持股量符合《上市規則》的要求。完成後，公司註冊資本相應減少人民幣15,467,500元，並將進行相關的公司章程修改及備案登記手續。股份註銷後，H股股份數目由402,543,650股減至387,076,150股。董事會成員包括執行董事李革博士等，以及非執行董事和獨立非執行董事。
On January 15, 2024, Ming Cong completed the repurchase and write-down of shares involved in the 2023 H Share Reward Trust Scheme involving a total of 15,467,500 shares representing approximately 0.52% of the Company's issued share capital. This repurchase and write-off was made in accordance with the special resolution of the General Meeting of Shareholders on 5 January 2024 and will not affect the compliance of the Company's public shareholding with the Listing Rules. Upon completion, the registered capital of the company will be reduced by RMB15,467,500 accordingly, and the relevant amendments to the articles of association and filing of registration will be carried out. After the share write-off, the number of H shares was reduced from 402,543,650 shares to 387,076,150 shares. Board members include Executive Director Dr. Li Geng, etc., as well as non-executive directors and independent non-executive directors.
On January 15, 2024, Ming Cong completed the repurchase and write-down of shares involved in the 2023 H Share Reward Trust Scheme involving a total of 15,467,500 shares representing approximately 0.52% of the Company's issued share capital. This repurchase and write-off was made in accordance with the special resolution of the General Meeting of Shareholders on 5 January 2024 and will not affect the compliance of the Company's public shareholding with the Listing Rules. Upon completion, the registered capital of the company will be reduced by RMB15,467,500 accordingly, and the relevant amendments to the articles of association and filing of registration will be carried out. After the share write-off, the number of H shares was reduced from 402,543,650 shares to 387,076,150 shares. Board members include Executive Director Dr. Li Geng, etc., as well as non-executive directors and independent non-executive directors.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1     View Translation

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more